Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Alignment Healthcare (ALHC) Interest Expenses (2020 - 2025)

Historic Interest Expenses for Alignment Healthcare (ALHC) over the last 6 years, with Q3 2025 value amounting to $4.0 million.

  • Alignment Healthcare's Interest Expenses fell 4305.9% to $4.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $17.3 million, marking a year-over-year decrease of 2632.65%. This contributed to the annual value of $23.5 million for FY2024, which is 1090.86% up from last year.
  • Latest data reveals that Alignment Healthcare reported Interest Expenses of $4.0 million as of Q3 2025, which was down 4305.9% from $4.0 million recorded in Q2 2025.
  • Alignment Healthcare's 5-year Interest Expenses high stood at $6.9 million for Q3 2024, and its period low was $4.0 million during Q1 2025.
  • Its 5-year average for Interest Expenses is $4.9 million, with a median of $4.6 million in 2022.
  • Its Interest Expenses has fluctuated over the past 5 years, first surged by 2691.18% in 2024, then crashed by 4305.9% in 2025.
  • Quarter analysis of 5 years shows Alignment Healthcare's Interest Expenses stood at $4.5 million in 2021, then grew by 7.66% to $4.8 million in 2022, then rose by 14.42% to $5.5 million in 2023, then grew by 0.15% to $5.5 million in 2024, then dropped by 28.08% to $4.0 million in 2025.
  • Its Interest Expenses was $4.0 million in Q3 2025, compared to $4.0 million in Q2 2025 and $4.0 million in Q1 2025.